Share on StockTwits

Research analysts at Raymond James reduced their target price on shares of AngioDynamics (NASDAQ:ANGO) from $19.00 to $18.00 in a report released on Friday, Stock Ratings Network.com reports. Raymond James’ target price points to a potential upside of 28.39% from the stock’s previous close.

AngioDynamics (NASDAQ:ANGO) traded up 0.86% during mid-day trading on Friday, hitting $14.02. 134,693 shares of the company’s stock traded hands. AngioDynamics has a 52 week low of $10.53 and a 52 week high of $19.00. The stock has a 50-day moving average of $14.3 and a 200-day moving average of $15.61. The company has a market cap of $494.5 million and a P/E ratio of 137.62. AngioDynamics also was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 752,009 shares, a growth of 47.5% from the April 15th total of 509,873 shares. Approximately 3.0% of the shares of the stock are sold short. Based on an average daily volume of 170,985 shares, the days-to-cover ratio is currently 4.4 days.

AngioDynamics (NASDAQ:ANGO) last announced its earnings results on Wednesday, April 9th. The company reported $0.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.07. The company had revenue of $88.20 million for the quarter, compared to the consensus estimate of $86.85 million. During the same quarter in the previous year, the company posted $0.08 earnings per share. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. Analysts expect that AngioDynamics will post $0.30 EPS for the current fiscal year.

ANGO has been the subject of a number of other recent research reports. Analysts at TheStreet downgraded shares of AngioDynamics from a “buy” rating to a “hold” rating in a research note on Thursday, April 17th. Analysts at Canaccord Genuity raised their price target on shares of AngioDynamics from $15.50 to $16.25 in a research note on Thursday, April 10th.

AngioDynamics, Inc designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.